Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  LIGHTHOUSE CAPITAL PARTNERS V LP
2. Date of Event Requiring Statement (Month/Day/Year)
06/13/2005
3. Issuer Name and Ticker or Trading Symbol
HEMOSENSE INC [HEMO]
(Last)
(First)
(Middle)
500 DRAKE'S LANDING ROAD
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

GREENBRAE, CA 94904-3011
6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series C-3 Preferred Warrant (right to buy)   (1) 03/05/2011 Series C-3 Preferred Stock 237,342 (2) $ 1.58 (2) D (3)  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
LIGHTHOUSE CAPITAL PARTNERS V LP
500 DRAKE'S LANDING ROAD
GREENBRAE, CA 94904-3011
    X    
LIGHTHOUSE MANAGEMENT PARTNERS V LLC
500 DRAKE'S LANDING ROAD
GREENBRAE, CA 94904-3011
    X    

Signatures

/s/ Dennis Ryan, Chief Financial Officer 06/13/2005
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Immediately.
(2) Pursuant to a 1-for-4 reverse stock split of the issuer's Common Stock effectuated on May 4, 2005 and the automatic conversion of each share of Series C-3 Preferred Stock into 0.25 shares of Common Stock immediately prior to the closing of the issuer's initial public offering on or around June 17, 2005, this warrant will be exercisable for 59,335 shares of Common Stock at an exercise price of $6.32 per share.
(3) The reported securities are owned directly by Lighthouse Capital Partners V, L.P. and indirectly by Lighthouse Management Partners V, L.L.C., as general partner of Lighthouse Capital Partners V, L.P. Lighthouse Management Partners V, L.L.C. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.